Skip to main content

Hanley Jr. Michael Conick's Form 4 filing

Alto Neuroscience, Inc.ANRO · filed Nov 18, 2026

Accession no.
0001791413-26-000002
Filed
Nov 18, 2026, 7:32 PM ET
Trade date
Nov 16-18, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.07M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hanley Jr. Michael ConickCIK 0001791413Officer (CHIEF OPERATING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2026Common StockMOption exerciseAcquired+17,729$2.35+$41,663.1517,729Direct
Nov 16, 2026Common StockMOption exerciseAcquired+44,271$2.35+$104,036.8562,000Direct
Nov 16, 2026Common StockMOption exerciseAcquired+8,000$2.35+$18,80070,000Direct
Nov 16, 2026Common StockSSaleDisposed−56,410$27.46F2−$1,549,187.8313,590Direct
Nov 16, 2026Common StockSSaleDisposed−10,895$28.43F3−$309,706.722,695Direct
Nov 16, 2026Common StockSSaleDisposed−2,695$29.09F4−$78,387.580Direct
Nov 17, 2026Common StockMOption exerciseAcquired+2,104$2.35+$4,944.42,104Direct
Nov 17, 2026Common StockSSaleDisposed−2,104$26.82−$56,420.860Direct
Nov 18, 2026Common StockMOption exerciseAcquired+2,896$2.35+$6,805.62,896Direct
Nov 18, 2026Common StockSSaleDisposed−2,896$26.48−$76,686.080Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 16, 2026Common StockMOption exerciseDisposed−17,729$0.00$0170,271Direct
Nov 16, 2026Common StockMOption exerciseDisposed−44,271$0.00$080,729Direct
Nov 16, 2026Common StockMOption exerciseDisposed−8,000$0.00$00Direct
Nov 17, 2026Common StockMOption exerciseDisposed−2,104$0.00$0168,167Direct
Nov 18, 2026Common StockMOption exerciseDisposed−2,896$0.00$0165,271Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $26.95 to $27.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $27.95 to $28.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $28.95 to $29.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)